Drug survival of infliximab and adalimumab in inflammatory bowel disease.
作者信息
Asadipour Erfan, Kargar Mona
机构信息
Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran.
出版信息
Int J Clin Pharm. 2020 Dec;42(6):1521-1523. doi: 10.1007/s11096-020-01151-9. Epub 2020 Oct 21.
PMID:33085041
Abstract
摘要
相似文献
1
Drug survival of infliximab and adalimumab in inflammatory bowel disease.英夫利昔单抗和阿达木单抗在炎症性肠病中的药物生存期
Int J Clin Pharm. 2020 Dec;42(6):1521-1523. doi: 10.1007/s11096-020-01151-9. Epub 2020 Oct 21.
2
Letter: infliximab therapy for patients with inflammatory bowel disease--some unanswered questions.信函：英夫利昔单抗治疗炎症性肠病患者——一些未解决的问题。
Aliment Pharmacol Ther. 2015 Nov;42(9):1133. doi: 10.1111/apt.13385.
3
Letter: infliximab therapy for patients with inflammatory bowel disease--some unanswered questions. Authors' reply.信函：英夫利昔单抗治疗炎症性肠病患者——一些未解决的问题。作者回复。
Aliment Pharmacol Ther. 2015 Nov;42(9):1134. doi: 10.1111/apt.13396.
4
Comparison of drug survival between infliximab and adalimumab in inflammatory bowel disease.比较英夫利昔单抗和阿达木单抗治疗炎症性肠病的药物生存情况。
Int J Clin Pharm. 2020 Apr;42(2):500-507. doi: 10.1007/s11096-020-00978-6. Epub 2020 Jan 31.
5
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease.治疗药物监测改善儿童炎症性肠病抗 TNF 药物的疗效。
Expert Opin Drug Metab Toxicol. 2019 Jul;15(7):527-539. doi: 10.1080/17425255.2019.1630378. Epub 2019 Jun 14.
6
Anti-TNF Agents in Elderly IBD Patients: Cause for Concern?老年炎症性肠病患者使用抗 TNF 药物：值得担忧吗？
J Crohns Colitis. 2020 Jul 30;14(7):881-882. doi: 10.1093/ecco-jcc/jjaa025.
7
Anti-TNF-α agents and serum lipids in inflammatory bowel diseases.炎症性肠病中的抗TNF-α药物与血脂
Clin Res Hepatol Gastroenterol. 2016 Sep;40(4):e46-7. doi: 10.1016/j.clinre.2015.12.009. Epub 2016 Feb 3.
8
9
Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays.采用新西兰检测方法评估英夫利昔单抗和阿达木单抗浓度及抗药物抗体对炎症性肠病的控制效果。
Intern Med J. 2019 Apr;49(4):513-518. doi: 10.1111/imj.14064.
10
[Biological drugs in inflammatory bowel disease: Management and care].[炎症性肠病中的生物药物：管理与护理]
Rev Esp Enferm Dig. 2015 Jul;107(7):454.
Zotero 插件